Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | BAX | Q07812 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22795111 | 0.70 | LTA4H (0.41) | LTA4HTSHRCA5ACA5BALDH1A1 | |
| SCHEMBL247036 | 0.59 | — | — | |
| SCHEMBL9052201 | 0.59 | — | — | |
| SCHEMBL26686884 | 0.59 | — | — | |
| SCHEMBL247035 | 0.59 | — | — | |
| SCHEMBL7363159 | 0.59 | LTA4H (0.45) | LTA4HTSHRCA5ACA5BALDH1A1 | |
| SCHEMBL306544 | 0.59 | — | — | |
| SCHEMBL3897634 | 0.59 | — | — | |
| SCHEMBL872933 | 0.59 | — | — | |
| SCHEMBL27231468 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1221447-B1 | Alkyl Cobalt (III) Dioximates and process for forming the same | DU PONT (US) | 2007-10-03 | — | — | EP | disclosed |
| US-6858745-B2 | Alkyl cobalt (III) dioximates and process for forming the same | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-02-22 | — | — | US | disclosed |
| US-6740618-B2 | REACTIN A GLYOXIME, A COBALT SALT, AN UNSATURATED COMPOUND SUCH AS AN ALKYL ACRYLATE, AND A LEWIS BASE IN H2; USE AS A POLYMERIZATION CATALYST, ESPECIALLY IN POLYMERIZING METHYL METHACRYLATE | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-05-25 | — | — | US | disclosed |
| US-6713427-B2 | TREATING A MIXTURE OF A COBALT (II) SALT, A DIOXIME OF THE FORMULA R1-C( HORIZONTAL-LINE NOH)-C( HORIZONTAL-LINE NOH)-R2, AN ACRYLIC ESTER, A LEWIS BASE WITH MOLECULAR HYDROGEN TO FORM A COBALT DIOXIMATE COMPLEX | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-03-30 | — | — | US | disclosed |
| US-20030149275-A1 | Alkyl cobalt (III) dioximates and process for forming the same | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2003-08-07 | — | — | US | disclosed |
| US-20030135054-A1 | Alkyl cobalt(III) dioximates and process for forming the same | GRIDNEV ALEXEI A (US) | 2003-07-17 | — | — | US | disclosed |
| US-20030125564-A1 | Alkyl cobalt (III) dioximates and process for forming the same | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2003-07-03 | — | — | US | disclosed |
| US-6559327-B2 | By reacting a cobalt salt, a dioxime such as diphenylglyoxime, a lewis base such as 1,2-dimethylimidazole, and an olefinic compound such as methyl acrylate, and treating with hydrogen; high yield, purity | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-05-06 | — | — | US | disclosed |
| EP-1221447-A2 | Alkyl Cobalt (III) Dioximates and process for forming the same | E. I. du Pont de Nemours and Company (US) | 2002-07-10 | — | — | EP | disclosed |
| US-20020087006-A1 | Alkyl cobalt (III) dioximates and process for forming the same | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2002-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149275-A1 | Alkyl cobalt (III) dioximates and process for forming the same | CCR3, CBR3, CCR6 | LTA4H 2875/4885TSHR 480/4885CA5A 102/4885 |
| US-20030125564-A1 | Alkyl cobalt (III) dioximates and process for forming the same | CCR3, CBR3, CCR6 | LTA4H 2846/4885TSHR 468/4885CA5A 101/4885 |
| US-20020087006-A1 | Alkyl cobalt (III) dioximates and process for forming the same | CCR3, CBR3, CCR6 | LTA4H 2846/4885TSHR 468/4885CA5A 101/4885 |
| US-20030135054-A1 | Alkyl cobalt(III) dioximates and process for forming the same | CCR3, CBR3, CCR6 | LTA4H 2846/4885TSHR 468/4885CA5A 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.